Nan Wang

Nan Wang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
NWNan Wang
Nan Wang
TLTianzi Li
Tianzi Li
WLWanyu Liu
Wanyu Liu
JLJinhua Lin
Jinhua Lin
KZKe Zhang
Ke Zhang
XLXuekui Liu
Xuekui Liu
GTPase-activating protein-binding protein 2 (G3BP2) is a key stress granule-associated RNA-binding protein responsible for the formation of stress granules (SGs). Hyperactivation of G3BP2 is associated with various pathological conditions, especially cancers. Emerging evidence indicates that post-translational modifications (PTMs) play critical roles in gene transcription, integrate metabolism and immune surveillance. However, how PTMs directly regulate G3BP2 activity is lacking. Here, our analyses identify a novel mechanism that PRMT5-mediated G3BP2-R468me2 enhances the binding to deubiquitinase USP7, which ensures the deubiquitination and stabilization of G3BP2. Mechanistically, USP7- and PRMT5-dependent G3BP2 stabilization consequently guarantee robust ACLY activation, which thereby stimulating de novo lipogenesis and tumorigenesis. More importantly, USP7-induced G3BP2 deubiquitination is attenuated by PRMT5 depletion or inhibition. PRMT5-activity dependent methylation of G3BP2 is required for its deubiquitination and stabilization by USP7. Consistently, G3BP2, PRMT5 and G3BP2 R468me2 protein levels were found positively correlated in clinical patients and associated with poor prognosis. Altogether, these data suggest that PRMT5-USP7-G3BP2 regulatory axis serves as a lipid metabolism reprogramming mechanism in tumorigenesis, and unveil a promising therapeutic target in the metabolic treatment of head and neck squamous carcinoma.

1 February 2022 in PeerJ
Verified
Journal Article
Open access
PDF file
NWNan Wang
Nan Wang
XHXuanyu Huang
Xuanyu Huang
JCJinsheng Cheng
Jinsheng Cheng
Background: Laryngeal squamous cell carcinoma (LSCC) remains one of the most common respiratory tumors worldwide. Baculoviral inhibitor of apoptosis repeat containing 5 (BIRC5) is a member of the inhibitor-of-apoptosis protein family. BIRC5 plays an important role in various types of cell proliferation, differentiation, migration and invasion. However, the specific role of BIRC5 in LSCC remains unclear. Methods: To provide a prognostic biomarker for LSCC, we screened the prognostic genes of LSCC via bioinformatics. PPI network and KEGG pathways were used to select hub genes. Clinical prognoses were performed using a Kaplan–Meier plotter and Cox proportional-hazard analysis. BIRC5 expression in LSCC tissues and cell lines were detected by RT-PCR, Western blot and Immunohistochemistry (IHC). Cell proliferation, cell cycle and cell apoptosis were detected with Cell Counting Kit-8 (CCK-8) and Flow Cytometry assay, respectively. Results: Here, BIRC5 was strongly correlated with higher tumor grade and differentiation. BIRC5 was highly expressed in LSCC tissues when compared with normal tissues and increased expression of BIRC5 was associated with overall survival in LSCC patients. The suppression of BIRC5 induced cell apoptosis and cell cycle arrest, thereby inhibiting the proliferation of LSCC cells. The survival analysis confirmed that higher level of BIRC5 expression predicted poor prognosis of LSCC patients. BIRC5 may act as an oncogene of LSCC development and was suggested as a promising prognostic biomarker for LSCC.

11 October 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
NWNan Wang
Nan Wang
YLYong Li
Yong Li
JZJianhong Zhou
Jianhong Zhou
MicroRNA-31 (miR-31) functions as tumor suppressors or oncogenes that are involved in tumor behavior. However, the function of miR-31 in cervical carcinogenesis remains unclear. The aim of this study was to validate the potential role of miR-31 and BRCA1-associated protein-1 (BAP1) on regulating epithelial-mesenchymal transition (EMT) in cervical cancer. In the present study, qRT-PCR assay revealed that the expression of miR-31 was upregulated in human cervical cancer cells and clinical tissues. Results of wound healing and cell migration assay revealed that knockdown of miR-31 inhibited cell metastasis and migration. Bioinformatic and dual-luciferase reporter gene assay showed that BAP1 was the direct target of miR-31. Furthermore, the results revealed that miR-31 promoted proliferation and EMT in cervical cancer cells and accelerated the development of tumor growth in vivo xenograft experiment by inhibiting BAP1 expression. Overall, these results highlight an important role of miR-31 functioning as an oncomir which could promote EMT in cervical cancer via downregulating BAP1 expression. Thus, downregulation of miR-31 could be a novel approach for the molecular treatment of cervical cancers and other malignancies.

5 September 2022 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
NWNan Wang
Nan Wang
XHXuanyu Huang
Xuanyu Huang
QLQian Long
Qian Long
Background: Altered lipid metabolism is associated with gastric cancer (GC) progression. Comprehensive analysis to identify critical lipid metabolic drivers for predicting overall survival (OS) is not fully elucidated in GC. Our study aim to explore a novel lipid metabolism-related prognostic marker for GC. Methods: Transcriptional status and clinical features were obtained from the TCGA-STAD database. The differentially expressed lipid metabolic genes and the risk prognostic model were developed by using bioinformatics and Cox regression analyses. ROC and Kaplan–Meier analysis were established to assess the performance of the risk predictive score model. GSE84437 dataset was used for external validation. Immunochemistry (IHC) was used to examine the expression of CYP19A1 in GC patients. Gene Set Enrichment Analysis (GSEA) was conducted to elucidate the underlying enriched mechanisms. TIMER and CIBERSORT analysis were performed to explore the relationship between CYP19A1 and immune microenvironment. Results: A novel lipid metabolic gene signature (including MTTP, CYP19A1, MYB, SERPINE1), and specifically CYP19A1, might be a promising prognostic factor for GC. Using the validation cohort, ROC curves indicate a good showing of our risk model. Based on the signature yielded a significant difference OS time between the low- and high-risk groups. Cox regression indicates that the signature is an independent prognostic variable. ROC curves present better and reliability predictive accuracy. The IHC data validate that high expression of CYP19A1 was found in GC tissues. GSEA analysis reveals that higher expression of CYP19A1 may significantly up-regulate genes involved in fatty acid metabolism and glycerolipid metabolism. CIBERSORT analysis suggests that CYP19A1 is related to the infiltration of multiple immune cells. Conclusion: CYP19A1 could be an independent prognostic factor and a novel metabolic-targeted treatment strategy for gastric cancer. Graphical Abstract:

10 January 2023 in Research Square
Verified
Preprint
Open access
PDF file
NWNan Wang
Nan Wang
XHXuanyu Huang
Xuanyu Huang
JCJinsheng Cheng
Jinsheng Cheng
Background:MYSM1 displays vital roles in hematopoiesis and lymphocyte development. However, the prognosis, immune infiltration and m6A modification role of MYSM1 in Head and Neck squamous carcinoma (HNSC) remains unexplored. Methods: A comprehensive bioinformatics analysis was used to identify the expression profiles and prognosis of MYSM1 in pan-cancer through multiple databases. TIMER and CIBERSORT database were used to analyze the relationship between MYSM1 expression and immune infiltration. GSEA and R language was utilized to estimate the functional enrichment analysis of MYSM1 in HNSC. The TCGA-HNSC cohort was used to investigate the relationship between MYSM1 expression and m6A modification in HNSC. Results: MYSM1 was differentially expressed in a variety of cancers including HNSC, and highly MYSM1 expression was associated with favorable overall survival (OS) and histological grade. CIBERSORT analysis showed that MYSM1 expression was significantly correlated with the infiltration of multiple immune cells. And the specific mechanism of MYSM1 regulating immune infiltration may be involved in the PD-L1 expression and PD-1 checkpoint pathway in cancer and TNF signaling pathway. TCGA-HNSC cohort analysis revealed that MYSM1 expression was related to 9 m6A modifier genes. Conclusion: Our comprehensive study found that MYSM1 can serve as a prognostic biomarker for determining prognosis, and is correlated with tumor immune infiltrating cells and m6A modification.

3 September 2026 in RSC Advances
Verified
Journal Article
Open access
HZHuang Zeng
Huang Zeng
MZManyi Zhang
Manyi Zhang
BQBo Qiu
Bo Qiu
SZShengyuan Zhang
Shengyuan Zhang
JLJiayao Liu
Jiayao Liu
NWNan Wang
Nan Wang
An integrated workflow combining machine learning-based predictive modeling with structure-based virtual screening and experimental validation, leading to the discovery of AO65 as a potent TDP1 inhibitor.